Latest IPSC Stories
MUMBAI, March 16, 2015 /PRNewswire/ -- Recent months have seen the first iPSC clinical trial in humans, creation of the world's largest iPSC biobank, major funding awards,
GERMANTOWN, Md., Nov.
WASHINGTON and NEW YORK and LONDON, Oct.
DALLAS, August 29, 2014 /PRNewswire/ -- Launched June 2014, the "Stem Cell Research Products - Opportunities, Tools, and Technologies" market intelligence report supplies
LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Complete 2013-14 Induced Pluripotent Stem Cell Industry Report for research supply companies to optimally position themselves to sell iPSC products. Dallas,
Reports indicate that stem cell research with induced pluripotent stem cells (iPSCs) is generally endorsed by the lay public despite several ethical concerns.
The ability to make induced pluripotent stem cells (iPSCs) from mature cells in the body holds great potential for improved drug screening, disease modeling, and medical treatments for numerous conditions.